Knowledge Center
White Paper / May 08, 2026
Integrated Nasal Powder Development Platform
Source:
Hovione White Paper
Why are nasal powders finally having their moment?
Nasal powder drug products are moving from niche to necessity. The intranasal route uniquely combines patient convenience, fast onset, and access to therapeutic spaces that are otherwise diffcult to reach, particularly the brain via olfactory and trigeminal pathways.
Related links
Also in the Knowledge Center
/ Sep 10, 2015
Continuous Precipitation of Nano-Crystals, Cocrystals and Amorphous Solid Dispersions
Read more
Scientific Article
/ Sep 10, 2015
Screening Methodologies to Expedite the Formulation Development of Amorphous Solid Dispersions
Read more
Scientific Article
/ Jul 27, 2015
Hovione and Invion sign development agreement for first inhaled non-steroidal anti-inflammatory for asthma
Read more
Scientific Article